The pediatric cardiology pharmacopeia: 2013 Update

Paul Nicholas Severin; Sawsan Awad; Beth Shields; Joan Hoffman; William Bonney; Edmundo Cortez; Rani Ganesan; Aloka Patel; Steve Barnes; Sean Barnes; Shada Al-Anani; Umang Gupta; Yolandee Bell Cheddar; Ismael E. Gonzalez; Kiran Mallula; Hani Ghawi; Suhaib Kazmouz; Salwa Gendi; Ra Id Abdulla

doi:10.1007/s00246-012-0553-8

The pediatric cardiology pharmacopeia: 2013 Update

Paul Nicholas Severin, Sawsan Awad, Beth Shields, Joan Hoffman, William Bonney, Edmundo Cortez, Rani Ganesan, Aloka Patel, Steve Barnes, Sean Barnes, Shada Al-Anani, Umang Gupta, Yolandee Bell Cheddar, Ismael E. Gonzalez, Kiran Mallula, Hani Ghawi, Suhaib Kazmouz, Salwa Gendi, Ra Id Abdulla

School of Medicine

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.

Original language	English (US)
Pages (from-to)	1-29
Number of pages	29
Journal	Pediatric Cardiology
Volume	34
Issue number	1
DOIs	https://doi.org/10.1007/s00246-012-0553-8
State	Published - Jan 2013

Keywords

Antiarrhythmic
Anticoagulants
Congestive heart failure
Diuretics
Fetal drugs
Inotropes
Pediatric cardiology
Pharmacologic agents
Pharmacopeia
Vasodilators

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/s00246-012-0553-8

Cite this

Severin, P. N., Awad, S., Shields, B., Hoffman, J., Bonney, W., Cortez, E., Ganesan, R., Patel, A., Barnes, S., Barnes, S., Al-Anani, S., Gupta, U., Cheddar, Y. B., Gonzalez, I. E., Mallula, K., Ghawi, H., Kazmouz, S., Gendi, S., & Abdulla, R. I. (2013). The pediatric cardiology pharmacopeia: 2013 Update. Pediatric Cardiology, 34(1), 1-29. https://doi.org/10.1007/s00246-012-0553-8

@article{7b5a007ad97347efaa185c00358bf242,

title = "The pediatric cardiology pharmacopeia: 2013 Update",

abstract = "The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.",

keywords = "Antiarrhythmic, Anticoagulants, Congestive heart failure, Diuretics, Fetal drugs, Inotropes, Pediatric cardiology, Pharmacologic agents, Pharmacopeia, Vasodilators",

author = "Severin, {Paul Nicholas} and Sawsan Awad and Beth Shields and Joan Hoffman and William Bonney and Edmundo Cortez and Rani Ganesan and Aloka Patel and Steve Barnes and Sean Barnes and Shada Al-Anani and Umang Gupta and Cheddar, {Yolandee Bell} and Gonzalez, {Ismael E.} and Kiran Mallula and Hani Ghawi and Suhaib Kazmouz and Salwa Gendi and Abdulla, {Ra Id}",

year = "2013",

month = jan,

doi = "10.1007/s00246-012-0553-8",

language = "English (US)",

volume = "34",

pages = "1--29",

journal = "Pediatric Cardiology",

issn = "0172-0643",

publisher = "Springer New York",

number = "1",

}

TY - JOUR

T1 - The pediatric cardiology pharmacopeia

T2 - 2013 Update

AU - Severin, Paul Nicholas

AU - Awad, Sawsan

AU - Shields, Beth

AU - Hoffman, Joan

AU - Bonney, William

AU - Cortez, Edmundo

AU - Ganesan, Rani

AU - Patel, Aloka

AU - Barnes, Steve

AU - Barnes, Sean

AU - Al-Anani, Shada

AU - Gupta, Umang

AU - Cheddar, Yolandee Bell

AU - Gonzalez, Ismael E.

AU - Mallula, Kiran

AU - Ghawi, Hani

AU - Kazmouz, Suhaib

AU - Gendi, Salwa

AU - Abdulla, Ra Id

PY - 2013/1

Y1 - 2013/1

N2 - The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.

AB - The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.

KW - Antiarrhythmic

KW - Anticoagulants

KW - Congestive heart failure

KW - Diuretics

KW - Fetal drugs

KW - Inotropes

KW - Pediatric cardiology

KW - Pharmacologic agents

KW - Pharmacopeia

KW - Vasodilators

UR - http://www.scopus.com/inward/record.url?scp=84872615249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872615249&partnerID=8YFLogxK

U2 - 10.1007/s00246-012-0553-8

DO - 10.1007/s00246-012-0553-8

M3 - Review article

C2 - 23192622

AN - SCOPUS:84872615249

SN - 0172-0643

VL - 34

SP - 1

EP - 29

JO - Pediatric Cardiology

JF - Pediatric Cardiology

IS - 1

ER -

The pediatric cardiology pharmacopeia: 2013 Update

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this